Gene Expression-Based High Throughput Screening: APL Treatment with Candidate Compounds
Source: NCBI BioProject (ID PRJNA89871)
Source: NCBI BioProject (ID PRJNA89871)
0 0
Project name: Homo sapiens
Description: We developed a general approach to small molecule library screening called GE-HTS (Gene Expression-Based High Throughput Screening) in which a gene expression signature is used as a surrogate for cellular states and applied it to the identification of compounds inducing the differentiation of acute myeloid leukemia cells. In screening 1,739 compounds, we identified 8 that reliably induced the differentiation signature, and furthermore yielded functional evidence of bona fide differentiation. We tested several of these in duplicate replicates in blasts from a patient with APL. Also included in this data set are a collection of 6 primary patient AML cells, 3 normal neutrophils samples, and 3 normal monocyte samples. This data was used to evaluate whole genome effects of the compounds on APL cells in relation to AML versus normal neutrophils and monocytes.Keywords = LeukemiaKeywords = APLKeywords = AMLKeywords = chemical genomicsKeywords: repeat sample
Data type: Transcriptome or Gene expression
Sample scope: Multiisolate
Relevance: Medical
Organization: Golub Lab, Cancer Genomics, Broad Institute
Literatures
- PMID: 14770183
Release date: 2004-01-30
Last updated: 2004-01-16